Skip navigation
Skip navigation

Prediction of Amyloid-β pathology in amnestic mild cognitive impairment with neuropsychological tests

Bahar-Fuchs, Alex; Villemagne, Victor; Ong, Kevin; Chetelat, Gael; Lamb, Fiona; Reininger, Cornelia B; Woodward, Michael; Rowe, Christopher


Assessment of disease biomarkers, particularly the in vivo assessment of amyloid-β (Aβ) burden with positron emission tomography (PET), is gradually becoming central to the diagnosis of mild cognitive impairment (MCI) due to Alzheimer's disease (AD). Ho

CollectionsANU Research Publications
Date published: 2013
Type: Journal article
Source: Journal of Alzheimer's Disease
DOI: 10.3233/JAD-2012-121315


File Description SizeFormat Image
01_Bahar-Fuchs_Prediction_of_Amyloid-β_2013.pdf303.16 kBAdobe PDFThumbnail

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator